David Wohl, M.D.
David Alain Wohl, M.D., is a professor in the Division of Infectious Diseases at the University of North Carolina at Chapel Hill (UNC). He is director of the North Carolina AIDS Training and Education Center, site leader of the University of North Carolina Chapel Hill AIDS Clinical Research Site and codirects HIV services for the North Carolina Department of Correction.
Dr. Wohl's research interests fall into two major areas: the metabolic complications of HIV and its therapies, and the nexus between incarceration and the HIV epidemic. He has chaired several related AIDS Clinical Trials Group (ACTG) studies and receives National Institutes of Health (NIH) funding for his corrections-related research.
Dr. Wohl serves as a member of the Department of Health and Human Services (DHHS) HIV treatment guidelines panel and the NIH Behavioral and Social Consequences of HIV study review section. In addition to his research and administrative activities, Dr. Wohl maintains a large HIV continuity clinic at UNC and sees patients at the North Carolina state prison.
Dr. Wohl has attended advisory boards for Abbott Laboratories, Tibotec and Gilead. In addition, his university received support for his research from GSK Merck.